About this file

This document is the FY24.C Small Business Technology Transfer (STTR) Proposal Submission Instructions for the Chemical and Biological Defense (CBD) Program, managed by the Joint Science and Technology Office for Chemical and Biological Defense (JSTO CBD) at the Defense Threat Reduction Agency (DTRA). The instructions establish requirements for proposals responding to the CBD STTR Program, which seeks to improve transition and commercialization of innovative chemical and biological defense technologies to the U.S. Military Joint Force. The program targets technology efforts including chemical and biological detection (point and stand-off capabilities), individual and collective protection, hazard mitigation and decontamination, medical pre-treatments and therapeutics, medical diagnostics, digital battlespace management, and health and human effects technologies including wearables. All proposals must be submitted via the Defense SBIR/STTR Innovation Portal (DSIP) at https://www.dodsbirsttr.mil; proposals submitted by other means will be disregarded.

Phase I proposals must not exceed 20 pages in the Technical Volume (Volume 2) with minimum 10-point font, with a maximum funding ceiling of $204,582.00 for a Period of Performance up to six months. Phase I selection is based on three evaluation criteria detailed in the DoD BAA, with awards subject to availability of funding and technical evaluation team approval. Phase II proposals may only be submitted after Phase I award receipt and at least five months into the Phase I contract performance period; Phase II budgets cover 24 months with potential cost-plus-fixed-fee or firm-fixed-price awards. All proposals require submission of seven volumes: Proposal Coversheet (Volume 1), Technical Volume (Volume 2), Cost Volume (Volume 3), Company Commercialization Report (Volume 4), Supporting Documents including mandatory Contractor Certification on Telecommunications and Video Surveillance (Volume 5), Fraud Waste and Abuse training completion (Volume 6), and Disclosures of Foreign Affiliations or Relationships to Foreign Countries webform (Volume 7). The CBD STTR Program reserves the right to withdraw from negotiations and limit awards based on superior scientific and technical quality determination. Research involving human subjects, human biospecimens, or animal use is prohibited in Phase I but may be proposed in Phase II; such research requires approval from the U.S. Army Medical Research and Development Command and DTRA Research Oversight Board prior to commencement. The program includes one approved FY24.C Phase I topic (CBD24C-T001) addressing cost-effective synthesis and processing of novel porous organic polymers for protective filtration applications, with Phase I objectives including synthesis of at least two porous organic polymers at 1 kg scale and preliminary detoxification studies of chemical warfare agent simulants.

View the file

Other files

File Type Posted
CBD24C-T001.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Cleared for Public Release

CBD STTR - 1

CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM

FY24.C Small Business Technology Transfer (STTR)

Proposal Submission Instructions

The approved FY24.C topic included in the Chemical and Biological Defense (CBD) Small Business

Technology Transfer (STTR) Program is provided in this document. Offerors responding to this

Announcement must follow all general instructions provided in the Department of Defense (DoD)

Program Announcement, as well as the CBD STTR Instructions provided below, detailing specific CBD

STTR program requirements.

Proposers are encouraged to thoroughly review the DoD Program Broad Agency Announcement

(BAA), as well as register for the DoD SBIR/STTR Innovation Portal (DSIP) Listserv to remain apprised of important programmatic and contractual changes.

• The DoD Program BAA: https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations. Be sure to select the tab for the appropriate BAA cycle.

• Register for the DSIP Listserv at: https://www.dodsbirsttr.mil/.

Please read the entire DoD Announcement and these CBD STTR instructions carefully prior to submitting your proposal. Important programmatic changes have been incorporated as required by the

SBIR and STTR Extension Act of 2022 (Pub. L. 117-183). Also, go to https://www.sbir.gov/about/about-sbir#sbir-policy-directive to read the SBIR/STTR Policy Directive issued by the U. S. Small Business

Administration (SBA).

INTRODUCTION

In response to Congressional interest in the readiness and effectiveness of U.S. Nuclear, Biological and

Chemical (NBC) warfare defenses, Title XVII of the National Defense Authorization Act for Fiscal Year

1994 (Public Law 103-160) requires the Department of Defense (DoD) to consolidate management and oversight of the Chemical and Biological Defense Program (CBDP) into a single office – Office of the

Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. The Joint

Science and Technology Office for Chemical and Biological Defense (JSTO CBD), located at the

Defense Threat Reduction Agency (DTRA), provides the management for the Science and Technology component of the Chemical and Biological Defense Program. Technologies developed under the Small

Business Technology Transfer (STTR) Program have the potential to transition to the Joint Program

Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO CBRND) if the appropriate level of technology maturity is demonstrated. The JSTO CBD Science & Technology programs and initiatives improve defensive capabilities against Chemical and Biological Weapons of

Mass Destruction. The STTR portion of the CBD Program is managed by JSTO CBD.

The mission of the Chemical and Biological Defense Program is to ensure that the U.S. Military has the capability to operate effectively and decisively in the face of chemical or biological warfare threats at home or abroad. Numerous factors continually influence the program and its technology development priorities. Improved defensive capabilities are essential in order to mitigate the overall impact of chemical and biological threats. The U.S. military requires the finest state-of-the-art equipment and instrumentation available to permit our Joint Force to ‘detect to warn’ and avoid contamination, if possible – and to be able to sustain operations in a potentially contaminated environment. Further information is available at the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and

Biological Defense Programs homepage at https://www.acq.osd.mil/ncbdp/cbd/.

The overall objective of the CBD STTR Program is to improve the transition or transfer of innovative

Chem-Bio technologies to the end user – the Joint Force – in addition to commercializing technologies https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/ https://www.sbir.gov/about/about-sbir#sbir-policy-directive https://www.sbir.gov/about/about-sbir#sbir-policy-directive https://www.acq.osd.mil/ncbdp/cbd/

CBD STTR - 2

within the private sector for mutual benefit. The CBD STTR Program targets those technology efforts that maximize a strong defensive posture in a biological or chemical environment using passive and active means as deterrents. These technologies include chemical and biological detection for both point and stand-off capabilities; individual and collective protection; hazard mitigation (decontamination);

medical pre-treatments (e.g., vaccine development and delivery); medical therapeutics (chemical and biological countermeasures); medical diagnostics; Digital Battlespace Management (a.k.a., information systems technology) to include but not limited to modeling and simulation (e.g., meteorological dispersion), disease surveillance, data fusion, and health & human effects to include wearable technologies.

All proposals submitted to the CBD STTR program must comply to the terms of this Announcement.

CBD STTR reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality, as determined by Technical Evaluation Team and the CBD STTR program office will be funded. CBD STTR reserves the right to withdraw from negotiations at any time prior to contract award. The Government may withdraw from negotiations at any time for any reason to include matters of national security (foreign persons, foreign influence or ownership, or other related issues).

Use of Foreign Nationals (also known as Foreign Persons), Green Card Holders, and Dual Citizens

See the “Foreign Nationals” section of the DoD STTR Program Announcement for the definition of a

Foreign National (also known as Foreign Persons).

It is the responsibility of ALL offerors proposing to use foreign nationals, green-card holders, or dual citizens, MUST disclose this information regardless of whether the topic is subject to export control restrictions. Offerors MUST Identify any foreign nationals or individuals holding dual citizenship expected to be involved on this project as a direct employee, subcontractor, or consultant. For these individuals, specify their country of origin, the type of visa or work permit under which they are performing and an explanation of their anticipated level of involvement on the project. You may be asked to provide additional information during contract negotiations to verify the foreign citizen’s eligibility to participate on a STTR contract. Supplemental information provided in response to this paragraph will be protected in accordance with the Privacy Act (5 U.S.C. 552a), if applicable, and the Freedom of

Information Act (5 U.S.C. 552(b)(6)).

Proposers responding to a topic in this BAA must follow all general instructions provided in the

Department of Defense (DoD) STTR Program BAA, paying special attention to the new requirements under the SBIR and STTR Extension Act of 2022 (Pub. L. 117-183). The Chemical and Biological

Defense STTR Program requirements are provided in the instructions below.

Specific questions pertaining to the administration of the Chemical and Biological Defense STTR

Program and these proposal preparation instructions should be directed to: Ms. Abigail L. Roots, Chemical and Biological Defense SBIR/STTR Program Manager, JSTO CBD, at dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil.

mailto:dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil

CBD STTR - 3

PHASE I PROPOSAL GUIDELINES

The Defense SBIR/STTR Innovation Portal (DSIP) is the official portal for DoD SBIR/STTR proposal submission. Firms are required to submit proposals via DSIP; proposals submitted by any other means will be disregarded. Detailed instructions regarding registration and proposal submission are provided in the DoD STTR Program BAA.

Proposal Coversheet (Volume 1)

The proposal coversheet must follow the instructions and requirements provided in the DoD STTR

Program BAA.

The offeror shall certify that to the best of their knowledge and belief, its eligibility information under the

STTR Program is accurate, complete, and current as of the date of the offer.

Technical Volume (Volume 2)

The Technical Volume is not to exceed 20-pages and must follow the formatting requirements provided in the DoD STTR Program BAA. No other information included in the other proposal volumes will count against the 20-page Proposal Technical Volume page limit. Pages provided exceeding this length will not be considered for review. The proposal must not contain any font type smaller than 10-point font size (except as a legend on reduced drawings, but not in the tables).

The maximum dollar amount for a Phase I proof-of-concept/feasibility study is $204,582.00 for a Period of Performance (PoP) of up to six (6) months. The CBD STTR Program will not accept proposals exceeding this amount for the Phase I effort.

The entire proposal submission must be through the Defense SBIR/STTR Innovation Portal (DSIP) located at: https://www.dodsbirsttr.mil. Any questions pertaining to the DoD SBIR/STTR submission process and system should be directed to DSIP Support: DoDSBIRSupport@reisystems.com

Selection of Phase I proposals will be based upon the three (3) evaluation criteria as mentioned in the

DoD BAA. The CBD STTR Program reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality deemed by the Technical Evaluation Team will be funded. All STTR contract awards, both Phase I and Phase II, are subject to availability of funding.

The brief Period of Performance available for a Phase I project precludes plans that include research involving human or animal subjects as all associated DoD requirements and the necessary approvals must be strictly adhered to and require considerable coordination and significant time for final protocol approvals. See “Research Involving Human Subjects, Biospecimens, and/or Animal Use,” below for further information.

Proposals not conforming to the terms of this Announcement, and any unsolicited proposals, will not be considered. All awards are subject to the availability of funding and successful completion of contract negotiations. The Chemical and Biological Defense Program is not responsible for any funds expended by the proposer prior to contract award.

Cost Volume (Volume 3)

The Cost Volume must follow all instructions and requirements provided in the DoD STTR Program

BAA. The Phase I Base amount must not exceed $204,582.00. Total Base cost for Phase I must be clearly identified on the Proposal Cover Sheet (Volume 1) and in Volume 3.

https://www.dodsbirsttr.mil/ mailto:DoDSBIRSupport@reisystems.com

CBD STTR - 4

Company Commercialization Report (CCR) (Volume 4)

Completion of the CCR is required and must be included in Volume 4 of the DSIP portal. Please refer to the DoD STTR Program BAA for full details on this requirement. Information contained in the CCR will not be considered by the Chemical and Biological Defense Program in the proposal evaluations.

Supporting Documents (Volume 5)

Please note proposals are required to include additional forms, as listed below Failure to submit the following document to Volume 5 will automatically result in disqualification of the Small Business

Concern (SBC) from receiving a STTR award for that proposal:

1. Contractor Certification Regarding Provision of Prohibition on Contracting for Certain

Telecommunications and Video Surveillance Services or Equipment

Offerors are welcome to provide additional Supporting Documents in this section, however these documents will not be considered by the Chemical and Biological Defense Program in the proposal evaluations.

Fraud, Waste and Abuse (Volume 6)

All offerors must complete the Fraud, Waste, and Abuse training through the DSIP portal

(https://www.dodsbirsttr.mil). Please follow the guidance provided via DSIP to complete the required training prior to proposal submission.

To Report Fraud, Waste, or Abuse, please contact:

DoD Inspector General (IG) Fraud, Waste & Abuse

Hotline: (800) 424-9098 hotline@dodig.mil

Additional information on Fraud, Waste and Abuse may be found in the DoD Announcement.

Disclosures of Foreign Affiliations or Relationships to Foreign Countries (Volume 7)

Small business concerns must complete the Disclosures of Foreign Affiliations or Relationships to

Foreign Countries webform in Volume 7 of the DSIP proposal submission. Please be aware that the

Disclosures of Foreign Affiliations or Relationships to Foreign Countries WILL NOT be accepted as a

PDF Supporting Document in Volume 5 of the DSIP proposal submission. Do not upload any previous versions of this form to Volume 5. For additional details, please refer to the DoD STTR Program BAA.

PHASE II PROPOSAL GUIDELINES

Offerors may only submit a Phase II proposal after receipt of a Phase I award.

Phase II is the demonstration of the technology that was found feasible in Phase I. A Phase II proposal may not be submitted until sufficient Phase I progress can be evaluated and assessed, and the PoP is nearing completion. The SBC may not submit a Phase II proposal sooner than five (5) months from the date of the Phase I contract award, and upon receiving instructions from the CBD program office.

All Phase II proposal submissions must be submitted on the DSIP portal:

https://www.dodsbirsttr.mil.

At the DSIP website, Phase II proposals MUST be submitted to ‘CBD STTR’ regardless of which DoD contracting office negotiated and awarded the Phase I contract. Additional instructions regarding the https://www.dodsbirsttr.mil/ mailto:hotline@dodig.mil https://www.dodsbirsttr.mil/

CBD STTR - 5

Phase II proposal submission process including submission dates will be provided to Phase I awardees after the Phase I contract is awarded.

The Phase II proposal must include a concise summary of the Phase I project including the specific technical problem or opportunity addressed in the proposal. The proposal must also include an objective statement, the type of research conducted, findings and/or results of the research, and technical feasibility of the technology. Due to limited funding, the CBD STTR program reserves the right to limit awards under any topic and only proposals considered to be of superior quality will be funded.

All proposers are required to submit a commercialization plan that describes the SBC’s marketing and manufacturing approach to developing the technology. The Offeror is required to submit a budget for the entire 24-month Phase II PoP. During contract negotiation, the Contracting Officer may require a Cost

Volume for a base year and an option year; thus, proposers are advised to be aware of this possibility.

These costs must be submitted using the Cost Volume format within the DSIP portal. The total proposed amount should be indicated on the Proposal Cover Sheet as the Proposed Cost. At the Contracting

Officer’s discretion, Phase II projects may be evaluated for technical progress prior to the end of the base year (year one) in order to determine whether to extend the funding for the option year (year two).

The CBD STTR Program is committed to minimizing the funding gap between Phase I and Phase II activities. The CBD STTR Program typically funds a cost-plus fixed fee Phase II award at the discretion of the Contracting Officer but may award a firm fixed price contract.

It is recommended that Phase II awardees have a Defense Contract Audit Agency (DCAA) approved accounting system. If you do not have a DCAA approved accounting system, this could delay/prevent a

Phase II contract award. Visit https://www.dcaa.mil/Customers/Small-Business for more information on

DCAA approved accounting systems.

DISCRETIONARY TECHNICAL AND BUSINESS ASSISTANCE (TABA)

Currently, the CBD STTR Program does not participate in the Technical and Business Assistance

(TABA) Program.

EVALUATION AND SELECTION

All proposals will be evaluated in accordance with the evaluation criteria listed in the DoD STTR

Program BAA.

Offerors will be notified of selection or non-selection within the 90-day window requirement at the close of the BAA. The CBD STTR Program Office will notify the firm via e-mail to the firm’s Corporate

Official (Business Point of Contact) and Principal Investigator, as listed on the Cover Page of the proposal.

The firm may submit an email request to the CBD SBIR/STTR inbox (dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil) to request a technical debrief. The CBD STTR Program Office will send a debriefing statement within 30-days of the request. The debriefing statement will only be provided to the

Corporate Official and the Principal Investigator, as listed on the Cover Page of the proposal. Requests made by the Offeror for further information will not be provided.

Refer to the DoD STTR Program BAA for guidance concerning protests.

As further prescribed in FAR 33.106(b), FAR 52.233-3, Protests after Award should be submitted to Ms.

Abigail L. Roots, Chemical and Biological Defense (CBD) SBIR/STTR Program Manager, Joint Science https://www.dcaa.mil/Customers/Small-Business

CBD STTR - 6

and Technology Office for Chemical and Biological Defense (JSTO CBD), dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil.

RESEARCH INVOLVING HUMAN SUBJECTS, BIOSPECIMENS, AND/OR ANIMAL USE

Any research under a Phase I or Phase II contract involving human subjects, human anatomical substances (e.g., whole blood, cell lines, tissue), and/or animal use must undergo the regulatory review requirements per DoD Instruction 3216.02 and DoD Instruction 3216.01, respectively.

DoD-level review and approval of human and/or animal use are separate from, and in conjunction with the Institutional Review Board (IRB) and/or the Institutional Animal Care and Use Committee (IACUC).

CBD STTR Projects Requiring Animal Subjects

Refer to the DoD Program BAA for Research Involving Animal Subjects.

Companies should plan carefully for any research involving animal subjects, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of

Concern (DURC)”. The mandatory DoD level review of this research is typically a period of no greater than four (4) months.

Projects under CBD STTR awards involving the use of animal subjects shall not be proposed for any

Phase I Period of Performance but may be proposed during the Phase II proposal submission.

Written authorization to begin animal research under the applicable protocol(s) proposed as part of the

CBD SBIR/STTR program will be issued after the contract award in the form of an approval memo from the U.S. Army Medical Research and Development Command (MRDC), Animal Care and Use Review

Office (ACURO), and the Research Oversight Board (ROB) of the Defense Threat Reduction Agency

(DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.

The offeror is expressly forbidden from using or subcontracting for the use of animals in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the ACURO prior to implementation.

Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The ACURO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Animal Care and Use Committee (IACUC) review(s). Further information may be required if the proposal is successful.

CBD STTR Projects Requiring Human Subjects, Human Anatomical Substances, and/or Human Data

Refer to the DoD Program BAA for Research Involving Human Subjects and Recombinant DNA

Molecules.

Companies should plan carefully for any research involving human subjects, human data, and/or human biospecimens (e.g., blood, saliva, tissue), to include cadaveric specimens, hereafter referred to as

“research”, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically no greater than four (4) months.

CBD STTR - 7

Projects under CBD STTR awards involving the use of human subjects shall not be proposed for any

Phase I Period of Performance but may be proposed during the Phase II proposal submission.

Written authorization to begin the research under the applicable protocol(s) proposed as part of the CBD

SBIR/STTR program will be issued after the contract award in the form of an approval memo from the

U.S. Army Medical Research and Development Command (MRDC), Office of Human Research

Oversight (OHRO), and the Research Oversight Board (ROB) of the Defense Threat Reduction Agency

(DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.

The offeror is expressly forbidden from beginning the research in any manner prior to these approvals.

Furthermore, modifications to approved protocols require review and approval by the OHRO prior to implementation.

Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The OHRO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Review Board (IRB) review(s). Further information may be required if the proposal is successful.

CBD STTR - 8

CBD STTR FY24.C Phase I Topic Index

CBD24C-T001 Cost Effective Synthesis and Processing of Novel Porous Organic Polymers for

Protective Applications

CBD STTR - 9

CBD24C-T001 Cost Effective Synthesis and Processing of Novel Porous Organic Polymers for

Protective Applications RT&L

FOCUS AREA(S): General Warfighting Requirements (GWR)

TECHNOLOGY AREA(S): Chemical/Bio Defense, Materials/Processes

OBJECTIVE: Develop and demonstrate the scaled synthesis of porous organic polymers (POPs) such as polymers of intrinsic microporisity (PIMs) or covalent organic frameworks (COFs) and process them into functional form factors for protection applications.

DESCRIPTION: This topic seeks to scale the synthesis and processing of POPs to quantities sufficient for developing and integrating novel polymer-based protection technologies. POPs are a family of functional porous materials made from light elements with intrinsic porosity based on a set of rigid or semi-rigid building blocks. POPs can be amorphous or highly crystalline and are highly effective in adsorption and catalysis applications. PIMs have high capacities towards a variety of toxic chemicals due to their microporous nature and have some advantages over current filtration materials.1 COFs are also highly porous with tunable pore size and shape and have been shown to be highly effective in various filtration applications.2,3 The chemistry of both classes can be tuned to include different chemical functionalities on the pore walls that absorb and react with various chemicals and provide broad spectrum protection.4,5

PIMs and COFs can be processed into various form factors, including fibers, films, and foams, lending them useful in technologies such as novel helmet-integrated filters, textiles, and coatings.6-8 Furthermore, PIMs and COFs can change their refractive index or luminescence upon chemical adsorption, allowing for multifunctional sensing materials.9,10

The primary limitation to further implementation is related to the cost of large-scale synthesis and processing. Many of the monomers required to form PIMs or COFs are expensive, the synthesis conditions require harsh solvents at high temperatures and require complicated purification procedures to access high surface area materials. Similarly, processing into useful form factors also requires harsh solvents and in the case of COFs, in can be difficult to access sufficiently large crystal sizes and alignment.

Thus, we seek the development of novel synthesis and processing approaches to access POPs on sufficiently large scales to make functional forms, such as fibers, films, and foam. Multiple PIMs, COFs or other POPs will be synthesized targeting toxic industrial chemical removal (threshold) and sensing

(objective). Target chemicals include, but are not limited to, chlorine, nitrogen dioxide, ammonia, and sulfur dioxide.

PHASE I: The offeror(s) shall develop an approach to synthesis at least 2 POPs at a scale of 1 kg.

Optionally, POPs can be used as functional binders to complement activity of other porous materials such as metal-organic frameworks (MOFs). The materials synthesized will have a minimum porosity of 500 m2/g and be amenable to post-synthetic modification allowing for the integration of appropriate nucleophilic species. The offeror(s) shall perform a preliminary study of the detoxification of a chemical warfare agent simulant and will show substantial uptake (similar to broad spectrum reactive carbons) and reaction towards toxic chemicals of interest.

PHASE II: The offeror(s) shall build upon the method developed in Phase I to scale up POP synthesis to

20-100 kg quantities and optimize synthesis routes to minimize cost. Furthermore, cost-effective processing routes will be developed to transform powdered POPs into at least 1 functional form (e.g.

granule, bead, fiber, foam) useful for filtration which should be mechanically robust with a modulus of at least 5 GPa and strength of at least 0.5 GPA. Alternatively, the offeror(s) may develop a hybrid approach where the POP is both synthesized and processed in a single step from the constituent building blocks.

Development of form factors and prototype filters will be initiated targeting NIOSH CBRN chemicals.

PHASE III: The offeror(s) shall build upon methods developed in Phase I and Phase II to develop a fully functional prototype and collaborate with industry partners to develop technologies such as novel filters, textiles/suits, foams, sensors, and more.

PHASE III DUAL USE APPLICATIONS: First responder personnel, pesticide applications personnel, industrial/lab waste kits, water filtration, gas storage, etc. would all benefit from a health & safety perspective resulting from the proposed technology.

References:

1. Jung, D.; Das, P.; Atilgan, A.; Hupp, J. T.; Islamoglu, T.; Kalow, J.A.; Farha, O. K. “Reactive

Porous Polymers for Detoxification of a Chemical Warfare Agent Simulant” Chem. Mater. 2020, 32 (21), 9299.

2. Tan, K.T., Ghosh, S., Wang, Z. et al. Covalent organic frameworks. Nat Rev Methods Primers

2023, 3,1.

3. Yuan, S.; Li, X.; Zhu, J.; Zhang, G.; Puyvelde, P. V.; Van der Bruggen, B. “Covalent Organic

Frameworks for Membrane Separation” Chem. Soc. Rev. 2019, 48, 2665.

4. Jung, D.; Chen, Z.; Alayoglu, S.; Mian, M. R.; Goetjen, T. A.; Idrees, K. B.; Kirlikovali, K. O.;

Islamoglu, T.; Farha, O. K. “Postsynthetically Modified Polymers of Intrinsic Microporosity

(PIMs) for Capturing Toxic Gases” ACS Appl. Mater. Interfaces 2021, 13 (8), 10409.

5. Segura, J. L.; Royuela, S.; Ramos, M. M. “Post-synthetic Modification of Covalent Organic

Frameworks” Chem. Soc. Rev. 2019, 48, 3903.

6. Topuz, F.; Abdellah, M. H.; Budd, P. M.; Abdulhamid, M. A. “Advances in Polymers of Intrinsic

Microporosity (PIMs)-Based Materials for Membrane, Environmental, Catalysis, Sensing and

Energy Applications” Polymer Reviews 2024, 64 (1), 251.

7. Snider, V. G.; Hill, C. L. “Functionalized reactive polymers for the removal of chemical warfare agents: A review” Journal of Hazardous Materials 2023, 442, 130015.

8. Barnes, M. G.; McLeod, D. C.; Lambeth, R. H. “Highly Crystalline, Free-Standing Covalent

Organic Framework Films Produced Directly from Monomer Solutions” ACS Appl. Polym.

Mater. 2022, 4, 2017.

9. Rakow, N. A.; Wendland, M. S.; Trend, J. E.; Poirier, R. J.; Paolucci, D. M.; Maki, S. P.; Lyons, C. S.; Swierczek, M. J. “Visual Indicator for Trace Organic Volatiles” Langmuir 2010, 26 (6), 3767.

10. Liu, X.; Huang, D.; Lai, C.; Zeng, G.; Qin, L.; Wang, H.; Yi, H.; Li, B.; Liu, S.; Zhang, M.;

Deng, R.; Fu, Y.; Li, L.; Xue, W.; Chen, S. “Recent advances in covalent organic frameworks

(COFs) as a smart sensing material” Chem. Soc. Rev. 2019, 48, 5266.

KEYWORDS: porous organic polymer, covalent organic framework, polymers of intrinsic microporosity, protection, filtration, scaling, engineering, forming

CBD STTR - 10

File details come from the government source that posted it. Updated .